This is a phase III trial trying to determine whether 12-hour bed rest following thrombectomy for ischemic stroke is non-inferior to 24-hour bed rest by measure of outcomes on the modified Rankin Scale (mRS) at 90 days post bed rest.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Any movement out of bed
90 Day Modified Rankin Scale (mRS) score
Proportion of patients with a modified Rankin Scale score (min 0, max 5 with 0 being the best outcome) of 0-2 at 90 days
Time frame: 90 days post bed rest
Pneumonia
Determine whether rates of pneumonia are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.
Time frame: Duration of hospitalization stay, average 5 days
Venous Thromboembolism
Determine whether rates of Venous Thromboembolism (VTE) are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.
Time frame: Duration of hospitalization stay, average 5 days
Neurological Worsening
Determine whether rates of neurological worsening are at least similar in the two arms. Rates will be measured as percentages of the entire population at risk.
Time frame: Duration of hospitalization stay, average 5 days
Readmission
Determine whether rates of readmission are at least similar in the two arms.
Time frame: 90 days post bed rest
Length of Stay
Determine whether length of hospital stay are at least similar in the two arms. This will be measured in days.
Time frame: Duration of hospitalization stay, average 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.